B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MAPK3 (ERK1) activation

REACTOME PATHWAY
Reactome: R-HSA-1100566 genes43 compounds

The MAPK3 (ERK1) activation pathway (Reactome ID: R-HSA-110056) involves 6 genes and is affected by 43 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CDK1IL6JAK2MAP2K1MAPK3TYK2

Compounds Affecting MAPK3 (ERK1) activation

#CompoundTargets HitStudies
1Sorafenib300
2kenpaullone8
3alsterpaullone12
4sp600125117
5Dasatinib299
6pd980597
7trametinib296
8Axitinib298
9indirubin300
10Clofibrate299
11Fenofibrate297
12Sertraline1,000
13Cinnarizine299
14Clotrimazole296
15Rotenone300
16Apigenin 5,7,4'-trihydroxy-flavone,300
17chrysin300
18fisetin78
19Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
20Quercetin300
21Azauridine300
22Cladribine297
23Methylene Blue200
242-Methoxyestradiol300
25Astemizole Antihistamine drug now withdrawn from280
26Azathioprine300
27Calcitriol300
28Camptothecin300
29Cytarabine297
30dihydrorotenone13
31Podophyllotoxin14
32streptonigrin299
33Trifluridine295
34Tripterygium300
35plumbagin [Supplementary Concept]300
36isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
37withaferin300
38arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside) [Supplementary Concept] isolated from300
39Vemurafenib298
40Crizotinib298
41Methotrexate289
42pictilisib25
43Prednisolone1,000

About the MAPK3 (ERK1) activation Pathway

The MAPK3 (ERK1) activation pathway is catalogued in Reactome (ID: R-HSA-110056) and involves 6 genes. In the BiohacksAI corpus, 43 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CDK1, IL6, JAK2, MAP2K1, MAPK3.